Brian Pinto

491 total citations
23 papers, 224 citations indexed

About

Brian Pinto is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian Pinto has authored 23 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian Pinto's work include Coronary Interventions and Diagnostics (4 papers), Acute Myocardial Infarction Research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Brian Pinto is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Acute Myocardial Infarction Research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Brian Pinto collaborates with scholars based in India and United States. Brian Pinto's co-authors include Christoph U. Lehmann, Brandyn Lau, David R. Thiemann, Kenneth M. Shermock, Michael B. Streiff, Peggy S. Kraus, Elliott R. Haut, Deborah B. Hobson, Leigh Efird and Uday Jadhav and has published in prestigious journals such as PLoS ONE, Journal of Thrombosis and Haemostasis and Clinical Therapeutics.

In The Last Decade

Brian Pinto

19 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Pinto India 8 86 70 58 40 33 23 224
William D. Linn United States 11 119 1.4× 26 0.4× 57 1.0× 56 1.4× 15 0.5× 17 389
Patricia R. Wigle United States 13 82 1.0× 33 0.5× 52 0.9× 39 1.0× 27 0.8× 39 422
William Darko United States 10 78 0.9× 36 0.5× 29 0.5× 28 0.7× 17 0.5× 38 311
Ryan P. Radecki United States 9 56 0.7× 49 0.7× 32 0.6× 23 0.6× 25 0.8× 27 252
Richard S Slavik Canada 14 121 1.4× 33 0.5× 88 1.5× 105 2.6× 51 1.5× 31 531
Jeff Nagge Canada 7 160 1.9× 97 1.4× 58 1.0× 28 0.7× 16 0.5× 14 272
Lisa Harinstein United States 11 67 0.8× 30 0.4× 46 0.8× 124 3.1× 83 2.5× 20 356
Narith N. Ou United States 11 175 2.0× 73 1.0× 34 0.6× 72 1.8× 14 0.4× 23 465
Karen Dahri Canada 12 85 1.0× 52 0.7× 21 0.4× 91 2.3× 31 0.9× 44 427
Susan M. Garabedian‐Ruffalo United States 10 130 1.5× 90 1.3× 136 2.3× 93 2.3× 19 0.6× 14 478

Countries citing papers authored by Brian Pinto

Since Specialization
Citations

This map shows the geographic impact of Brian Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Pinto more than expected).

Fields of papers citing papers by Brian Pinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Pinto. The network helps show where Brian Pinto may publish in the future.

Co-authorship network of co-authors of Brian Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Pinto. A scholar is included among the top collaborators of Brian Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Pinto. Brian Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DiPiro, Joseph T., Erin R. Fox, Aaron S. Kesselheim, et al.. (2021). ASHP Foundation Pharmacy Forecast 2021: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems. American Journal of Health-System Pharmacy. 78(6). 472–497. 16 indexed citations
2.
Kaul, Upendra, Saumitra Ray, Kamal Sharma, et al.. (2020). Consensus document: management of heart failure in type 2 diabetes mellitus. Heart Failure Reviews. 26(5). 1037–1062. 3 indexed citations
3.
Pinto, Brian, et al.. (2020). ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction. Indian Heart Journal. 72(5). 345–350. 29 indexed citations
4.
Pinto, Brian, et al.. (2018). Indian Consensus on OPtimal Treatment of Angina (OPTA ).. PubMed. 66(12). 95–103. 1 indexed citations
5.
Goel, Pravin K., Ajit Menon, Ajit Mullasari, et al.. (2018). Transradial access for coronary diagnostic and interventional procedures: Consensus statement and recommendations for India. Indian Heart Journal. 70(6). 922–933. 4 indexed citations
6.
Kaul, Upendra, Ajit Bhagwat, Brian Pinto, et al.. (2017). Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trial. EuroIntervention. 13(10). 1194–1201. 6 indexed citations
7.
Dalal, Jamshed, et al.. (2016). Time to shift from contemporary to high-sensitivity cardiac troponin in diagnosis of acute coronary syndromes. Indian Heart Journal. 68(6). 851–855. 3 indexed citations
8.
9.
Fox, Brent I. & Brian Pinto. (2016). Digital Health Solutions: An Important Tool in Patient Engagement. Hospital Pharmacy. 51(6). 501–502. 1 indexed citations
10.
Pinto, Brian & Brent I. Fox. (2016). Clinical and Business Intelligence: Why It's Important to Your Pharmacy. Hospital Pharmacy. 51(7). 604–605. 1 indexed citations
11.
Bangalore, Sripal, et al.. (2016). Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non–Insulin-Treated Diabetes Mellitus. JAMA Cardiology. 1(3). 266–266. 21 indexed citations
12.
Lau, Brandyn, Elliott R. Haut, Deborah B. Hobson, et al.. (2013). Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. Value in Health. 16(3). A291–A291. 1 indexed citations
13.
Shermock, Kenneth M., Brandyn Lau, Elliott R. Haut, et al.. (2013). Patterns of Non-Administration of Ordered Doses of Venous Thromboembolism Prophylaxis: Implications for Novel Intervention Strategies. PLoS ONE. 8(6). e66311–e66311. 65 indexed citations
14.
Chopra, H K, et al.. (2013). The nuances of atherogenic dyslipidemia in diabetes: Focus on triglycerides and current management strategies. Indian Heart Journal. 65(6). 683–690. 9 indexed citations
15.
Bhandari, Suman, Ashok Seth, Kamal Kumar Sethi, et al.. (2012). Cardiological Society of India Practice Guidelines for Angiography in Patients with Renal Dysfunction. Indian Heart Journal. 64. S18–S43. 3 indexed citations
16.
Lau, Brandyn, Brian Pinto, David R. Thiemann, & Christoph U. Lehmann. (2011). Budget Impact Analysis of Conversion from Intravenous to Oral Medication When Clinically Eligible for Oral Intake. Clinical Therapeutics. 33(11). 1792–1796. 39 indexed citations
17.
Shermock, Kenneth M., Michael B. Streiff, Brian Pinto, Peggy S. Kraus, & Peter J. Pronovost. (2011). Novel analysis of clinically relevant diagnostic errors in point‐of‐care devices. Journal of Thrombosis and Haemostasis. 9(9). 1769–1775. 7 indexed citations
18.
Seth, Ashok, Nakul Sinha, Keyur Parikh, et al.. (2009). Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry.. PubMed. 60(4). 333–41.
19.
Pinto, Brian, et al.. (2009). Technical tips for transradial approach in post CABG interventions.. PubMed. 60(1 Suppl A). A38–41.
20.
Witmer, David R., et al.. (2005). National survey of dietary supplement policies in acute care facilities. American Journal of Health-System Pharmacy. 63(1). 65–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026